Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TERT promoter mutations and telomeres during tumorigenesis
Franziska K. Lorbeer, Dirk Hockemeyer
Current Opinion in Genetics & Development (2020) Vol. 60, pp. 56-62
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Genetics of human telomere biology disorders
Patrick Revy, Caroline Kannengiesser, Alison A. Bertuch
Nature Reviews Genetics (2022) Vol. 24, Iss. 2, pp. 86-108
Closed Access | Times Cited: 125
Telomerase in Cancer: Function, Regulation, and Clinical Translation
Nathaniel Robinson, William P. Schiemann
Cancers (2022) Vol. 14, Iss. 3, pp. 808-808
Open Access | Times Cited: 67
Telomeres, aging, and cancer: the big picture
Peter M. Lansdorp
Blood (2022) Vol. 139, Iss. 6, pp. 813-821
Open Access | Times Cited: 67
Human MettL3-MettL14 RNA adenine methyltransferase complex is active on double-stranded DNA containing lesions
Dan Yu, J.R. Horton, Jie Yang, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 20, pp. 11629-11642
Open Access | Times Cited: 62
Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer
Kamalakshi Deka, Yinghui Li
Cells (2023) Vol. 12, Iss. 5, pp. 788-788
Open Access | Times Cited: 34
TERT Promoter Mutations and Telomerase in Melanoma
Yuchen Guo, Yi Chen, Lianghui Zhang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 29
Genetic and clinical determinants of telomere length
Patrick D. Allaire, Jing He, John E. Mayer, et al.
Human Genetics and Genomics Advances (2023) Vol. 4, Iss. 3, pp. 100201-100201
Open Access | Times Cited: 18
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
Isabelle Schmutz, Arjen R. Mensenkamp, Kaori Takai, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 44
TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti‐CTLA4 treatment
Huahua Li, Jia Li, Chenyue Zhang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 19, pp. 7151-7160
Open Access | Times Cited: 40
Evolution of Diverse Strategies for Promoter Regulation
Václav Brázda, Martin Bartas, Richard P. Bowater
Trends in Genetics (2021) Vol. 37, Iss. 8, pp. 730-744
Open Access | Times Cited: 38
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Irene Vanni, Enrica T. Tanda, Bruna Dalmasso, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 32
Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang
Junfu Ma, Yanxin Yao, Ye Tian, et al.
Biology of Sex Differences (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
<i>TERT</i> promoter mutations in thyroid cancer
Michiko Matsuse, Norisato Mitsutake
Endocrine Journal (2023) Vol. 70, Iss. 11, pp. 1035-1049
Open Access | Times Cited: 12
Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview
Raluca-Margit Szilveszter, Mara Muntean, Adrian Florea
Biomolecules (2024) Vol. 14, Iss. 6, pp. 656-656
Open Access | Times Cited: 4
Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review
Serban Papacocea, Daniela Vrînceanu, Mihai Dumitru, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9714-9714
Open Access | Times Cited: 4
The impact of C216T and hot spot mutations of the TERT promoter on the clinicopathologic characteristics and S100A10 expression in papillary thyroid carcinoma: a comparative study
Ping Li, Chuqiang Huang, Xiaoling Liu, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Molecular insights into early malignant transition of hepatocellular carcinoma
Zhengtao Zhang, H. Li, Lingli Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition
Yahya Benslimane, María Sánchez‐Osuna, Jasmin Coulombe‐Huntington, et al.
Aging Cell (2021) Vol. 20, Iss. 4
Open Access | Times Cited: 26
Telomeres, Telomerase and Cancer
Peter M. Lansdorp
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 741-746
Open Access | Times Cited: 18
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 10
Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers
Bing He, Peng Gao, Yangyang Ding, et al.
Science Advances (2020) Vol. 6, Iss. 30
Open Access | Times Cited: 24
Novel copper complex CTB regulates methionine cycle induced TERT hypomethylation to promote HCC cells senescence via mitochondrial SLC25A26
Chun Jin, Yujia Li, Ying Su, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 24
Poly(beta-amino ester)-Based Nanoparticles Enable Nonviral Delivery of Base Editors for Targeted Tumor Gene Editing
Qimingxing Chen, Lili Su, Xiaoyan He, et al.
Biomacromolecules (2022) Vol. 23, Iss. 5, pp. 2116-2125
Closed Access | Times Cited: 14
Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations
Sama Alohali, Alexandra E. Payne, Marc Pusztaszeri, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 413-413
Open Access | Times Cited: 8
Occurrence, functionality and abundance of the TERT promoter mutations
Sivaramakrishna Rachakonda, Jörg D. Hoheisel, Rajiv Kumar
International Journal of Cancer (2021) Vol. 149, Iss. 11, pp. 1852-1862
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top